The term "PAU18" does not correspond to any documented antibody nomenclature in:
Structural classifications of SARS-CoV-2 neutralizing antibodies
Broad antibody characterization initiatives (e.g., YCharOS, Human Protein Atlas)
Possible reasons for the absence include:
Non-standard naming: PAU18 may be an internal project code or unpublished identifier.
Typographical error: Potential confusion with established antibodies (e.g., pembrolizumab, palivizumab) or ribosomal P protein antibodies (e.g., 9D5, 4H11) .
While PAU18 is unverified, recent advancements in antibody discovery and characterization provide insights into similar agents:
Emerging technologies could accelerate PAU18-like antibody discovery:
Microfluidics-enabled ASC screening: Enables isolation of high-affinity antibodies (<1 pM) in 2 weeks .
Structural-guided engineering: Utilizes cryo-EM and X-ray crystallography to optimize epitope binding (e.g., SARS-CoV-2 antibodies) .
KO cell line validation: Critical for confirming specificity, as demonstrated in YCharOS studies .
To resolve the ambiguity around PAU18:
Verify nomenclature with regulatory bodies (e.g., WHO’s INN, FDA Orange Book).
Explore patent databases for preclinical candidates.
Contact academic consortia (e.g., YCharOS, Human Protein Atlas) for unpublished data.
PAU18 belongs to the PAU (seriPAUper) family of proteins in Saccharomyces cerevisiae, which are induced under anaerobic conditions and other stress factors. These proteins are part of the cell wall and play roles in adaptation to environmental stresses. Studying PAU18 using specific antibodies helps understand yeast stress responses, cell wall dynamics, and potential applications in biotechnology. The PAU18 Antibody (CSB-PA316558XA01SVG) is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) PAU18 protein .
PAU18 antibodies should be stored at -20°C or -80°C upon receipt to maintain integrity and activity. Repeated freeze-thaw cycles should be avoided as they can degrade antibody quality and reduce binding affinity. The antibody is typically supplied in a liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . For short-term use (less than one week), storage at 4°C is acceptable, but long-term storage requires freezing temperatures.
The PAU18 antibody has been validated for specific research applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . These techniques allow for both quantitative analysis and qualitative detection of PAU18 protein in yeast samples. The antibody's specificity for Saccharomyces cerevisiae (strain ATCC 204508/S288c) makes it suitable for research focusing on this particular yeast strain. Researchers should conduct validation tests when applying this antibody to other strains or modified experimental conditions.
Determining optimal dilution factors requires empirical testing. For Western blotting, begin with a 1:1000 dilution and adjust based on signal-to-noise ratio. For ELISA applications, a titration series starting from 1:500 to 1:10,000 is recommended to establish the optimal working concentration. Factors affecting optimal dilution include:
Sample preparation method
Protein expression levels
Detection system sensitivity
Background interference
Always include appropriate controls to validate specificity and reduce non-specific binding. Titration experiments should be systematically documented to establish reproducible protocols for future experiments.
Validating antibody specificity is crucial for reliable results. Consider implementing these advanced validation approaches:
Knockout/knockdown controls: Compare wild-type yeast with PAU18 deletion strains to confirm specificity
Pre-absorption testing: Pre-incubate the antibody with purified recombinant PAU18 protein before immunoblotting to demonstrate binding specificity
Mass spectrometry confirmation: Perform immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody
Cross-reactivity assessment: Test against other PAU family proteins to evaluate potential cross-reactivity
A systematic validation approach should include quantitative assessment of binding affinity and specificity metrics. Document all validation experiments thoroughly to support publication requirements and reproducibility.
When experiencing inconsistent results with PAU18 antibodies, consider these methodological approaches:
Sample preparation optimization:
Test different lysis buffers to improve protein extraction
Evaluate the need for protease inhibitors to prevent degradation
Consider native vs. denaturing conditions based on epitope accessibility
Protocol modifications:
Adjust blocking reagents to reduce background
Optimize incubation times and temperatures
Test multiple detection systems
Antibody handling:
Avoid repeated freeze-thaw cycles
Consider aliquoting the antibody upon receipt
Verify storage conditions were maintained
Control implementation:
Include positive and negative controls in each experiment
Use loading controls appropriate for your experimental conditions
Systematically document all troubleshooting steps and outcomes to identify the critical variables affecting performance.
Optimizing immunoprecipitation (IP) for PAU18 requires careful consideration of multiple factors:
Lysis conditions:
Use gentle lysis buffers to preserve protein-protein interactions
Consider crosslinking to stabilize transient interactions
Optimize salt concentration to maintain specific interactions while reducing non-specific binding
Antibody coupling:
Direct coupling to beads may improve efficiency
Determine optimal antibody-to-bead ratio (typically 2-10 μg antibody per 50 μl bead slurry)
Consider orientation-specific coupling techniques to maximize epitope accessibility
Washing stringency:
Develop a gradient washing strategy with decreasing salt concentrations
Monitor protein retention after each washing step
Balance specificity (high stringency) with sensitivity (low stringency)
Elution methods:
Compare different elution strategies (pH, competitive, denaturing)
Evaluate elution efficiency through Western blotting
Consider sequential elution steps for comprehensive recovery
Careful optimization of each step will improve the quality of data obtained from IP experiments with PAU18 antibodies.
When investigating PAU18 expression under various stress conditions, consider these experimental design principles:
Time-course analysis:
Sample at multiple time points following stress induction
Include early time points (15, 30, 60 minutes) and extended periods (2, 4, 8, 24 hours)
Normalize expression to non-stressed controls at each time point
Dose-response relationships:
Test multiple intensities of the stress factor
Include sub-threshold and saturation conditions
Determine EC50 values for specific stress responses
Combinatorial stress conditions:
Investigate synergistic or antagonistic effects of multiple stressors
Design factorial experiments to identify interactions
Apply statistical models appropriate for multi-factorial designs
Single-cell vs. population-level analysis:
Consider heterogeneity in stress responses
Implement flow cytometry or microscopy for single-cell resolution
Compare with bulk measurements to identify population dynamics
| Stress Condition | Sampling Timepoints | Control Condition | Key Measurements |
|---|---|---|---|
| Anaerobic shift | 0, 0.5, 1, 2, 4, 8, 24 hrs | Aerobic growth | PAU18 protein levels, cell viability |
| Ethanol stress | 0, 0.5, 1, 2, 4, 8, 24 hrs | No ethanol | PAU18 localization, stress response genes |
| Temperature shift | 0, 0.5, 1, 2, 4, 8, 24 hrs | Optimal temperature | Membrane integrity, PAU18 expression |
| Nutrient limitation | 0, 2, 4, 8, 24, 48 hrs | Complete media | Growth rate, PAU18 distribution |
Discrepancies between protein abundance and transcript levels are common in biological systems. When facing contradictory results:
Consider post-transcriptional regulation:
Investigate mRNA stability and half-life
Examine translation efficiency through polysome profiling
Assess potential microRNA regulation
Evaluate protein stability and turnover:
Perform pulse-chase experiments to determine protein half-life
Investigate ubiquitination and proteasomal degradation
Examine autophagy contribution to protein turnover
Analyze temporal dynamics:
Ensure appropriate sampling resolution to capture rapid changes
Consider time delays between transcription and translation
Implement mathematical models to describe relationship dynamics
Technical considerations:
Validate antibody performance under the specific experimental conditions
Assess the dynamic range and limits of detection for both methods
Implement alternative orthogonal approaches for confirmation
Rigorous data analysis and appropriate statistical methods should be applied to distinguish biological variation from technical artifacts.
Analyzing PAU18 subcellular localization requires sophisticated imaging and fractionation approaches:
Immunofluorescence optimization:
Fixation method selection (formaldehyde vs. methanol)
Permeabilization optimization for yeast cell wall
Antibody concentration titration for optimal signal-to-noise ratio
Z-stack acquisition for complete cellular coverage
Subcellular fractionation:
Implement differential centrifugation protocols
Validate fraction purity with compartment-specific markers
Quantify PAU18 distribution across fractions via Western blotting
Compare native versus stress-induced conditions
Live-cell imaging approaches:
Create fluorescent protein fusions (if appropriate)
Validate functionality of tagged proteins
Implement time-lapse microscopy with appropriate temporal resolution
Consider photobleaching approaches to assess protein dynamics
Quantification methods:
Apply automated image analysis algorithms
Implement colocalization analysis with known markers
Develop quantitative metrics for distribution patterns
Apply appropriate statistical tests for comparative analysis
Modern research benefits from multi-omics integration. Consider these approaches:
Integration with proteomics:
Combine immunoprecipitation with mass spectrometry (IP-MS)
Identify PAU18 interactome changes under different conditions
Validate key interactions through reciprocal IP or proximity labeling
Correlation with transcriptomics:
Compare PAU18 protein levels with RNA-seq data
Identify co-regulated gene clusters
Implement network analysis to place PAU18 in regulatory pathways
Complementation with functional genomics:
Screen for genetic interactions using synthetic genetic arrays
Evaluate phenotypic effects of PAU18 manipulation
Correlate antibody-based measurements with functional outcomes
Integration with structural biology:
Use antibody epitope mapping to inform structural studies
Implement antibody-based techniques for conformational analysis
Correlate structural changes with functional outcomes
While PAU18 is not a typical DNA-binding protein, if investigating potential chromatin associations:
Crosslinking optimization:
Test different crosslinking agents (formaldehyde, DSG, EGS)
Optimize crosslinking time and temperature
Consider dual crosslinking for enhancing weak or transient interactions
Sonication parameters:
Develop a sonication protocol yielding 200-500 bp fragments
Verify fragment size distribution through gel electrophoresis
Ensure consistent fragmentation across samples
IP condition modifications:
Adjust salt concentrations to minimize non-specific chromatin binding
Implement stringent washing procedures
Include appropriate controls (IgG, input, non-enriched regions)
Data analysis considerations:
Apply appropriate peak calling algorithms
Implement controls for false discovery rate estimation
Validate findings with orthogonal methods (e.g., reporter assays)
Computational methods can significantly enhance antibody-based research:
Epitope prediction and analysis:
Implement bioinformatic tools to predict PAU18 epitopes
Assess epitope conservation across related proteins
Correlate epitope structure with antibody performance
Image analysis automation:
Develop machine learning algorithms for image segmentation
Implement automated quantification workflows
Apply statistical methods for robust comparisons
Network analysis:
Integrate PAU18 interaction data into broader networks
Identify functional modules and pathways
Predict functional consequences of perturbations
Molecular dynamics simulations:
Model antibody-antigen interactions
Predict effects of mutations on binding affinity
Guide experimental design for structure-function studies
Research with PAU18 antibodies can benefit from these emerging technologies:
Single-cell proteomics:
Apply microfluidic antibody-based methods for single-cell analysis
Correlate PAU18 levels with cell-to-cell variability in stress response
Identify rare cell populations with unique PAU18 expression patterns
Proximity labeling techniques:
Implement BioID or APEX2 fusion approaches
Map the spatial environment of PAU18 in different conditions
Identify transient interaction partners
Super-resolution microscopy:
Apply STORM, PALM, or STED for nanoscale localization
Resolve PAU18 distribution within yeast cell wall subdomains
Correlate localization patterns with functional outcomes
Antibody engineering:
Develop single-domain antibodies for improved penetration
Create bifunctional antibody constructs for specialized applications
Engineer antibody fragments for intracellular expression
PAU18 research has implications for fundamental biological understanding:
Evolutionary conservation of stress responses:
Compare PAU18 function with related proteins in other yeast species
Identify conserved mechanistic principles across species
Trace the evolutionary history of stress response mechanisms
Systems biology of stress adaptation:
Place PAU18 within the broader stress response network
Identify regulatory hubs and control points
Model dynamic responses and adaptation processes
Cell wall remodeling mechanisms:
Elucidate PAU18's role in cell wall structure during stress
Examine coordination between PAU family members
Investigate implications for antifungal resistance
Biotechnological applications:
Explore potential for engineering stress-resistant yeast strains
Develop biosensors based on PAU18 expression
Apply knowledge to industrial fermentation optimization